NDC 68071-5217-00 - GLYBURIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-5217
- Requested NDC
- 68071-5217-00
- Package NDCs from labels
- 68071-5217-0, 68071-5217-00
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2024-06-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glyburide Tablets, USP Rx only | NuCare Pharmaceuticals,Inc. | 2024-06-20 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-5217-0 | 2022-02-07 | C162847 | 48780-1 | d6a99b39-d523-a426-e053-dadaa90af4c2 | Glyburide Tablets, USP Rx only |
| 68071-5217-0 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-d523-a426-e053-dadaa90af4c2 | Glyburide Tablets, USP Rx only |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-5217-0 | GLYBURIDE | 100 in 1 BOTTLE | TABLET | 100 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-5217 | GLYBURIDE TABLET [NUCARE PHARMACEUTICALS,INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240622_a1233548-bbb8-34aa-e053-2a95a90aea53.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | Bryant Ranch Prepack | 4dcef36f-000e-43f5-8d67-0e2a079ab2c6 | 2026-08-18 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| glyburide-metformin hydrochloride | GLYBURIDE-METFORMIN HYDROCHLORIDE | Bryant Ranch Prepack | b5ccf5da-cbe1-4009-ba1c-990050838ee9 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| glyburide-metformin hydrochloride | GLYBURIDE-METFORMIN HYDROCHLORIDE | Bryant Ranch Prepack | a086cc29-cb5d-40d0-a57d-8e91f1aa9158 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| glyburide-metformin hydrochloride | GLYBURIDE-METFORMIN HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | b38213bb-d663-4c95-a1b2-96c23ee5be09 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 372af566-d6ec-446f-88db-0b4cc83b577f | 2026-07-03 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | Aurobindo Pharma Limited | 7010b662-8b34-49ce-8e5b-73dee0821a60 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| Glyburide | GLYBURIDE | REMEDYREPACK INC. | 524eec41-37ee-419a-b7a1-d23e888ae6ab | 2026-06-12 | Warnings, Adverse reactions | 310537 SX6K58TVWC |
| glyburide and metformin hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | Zydus Pharmaceuticals (USA) Inc. | 2239742b-74e1-4bc2-b5a8-15c4758d6f7b | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| glyburide and metformin hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | Zydus Lifesciences Limited | df752bd4-e197-40a4-a01b-d48ba2c10516 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| GLYBURIDE | GLYBURIDE | Bryant Ranch Prepack | 9cdd30e7-512a-4f00-a4de-0a154d143ce9 | 2026-05-18 | Adverse reactions | ANDA090937 310534 SX6K58TVWC |
| Glyburide | GLYBURIDE | REMEDYREPACK INC. | e23b9a3b-0184-4d1c-8e2c-668697a6da87 | 2026-05-15 | Warnings, Adverse reactions | 310534 SX6K58TVWC |
| Glyburide | GLYBURIDE | Preferred Pharmaceuticals Inc. | cf21c8c0-7247-4d5b-97f8-ae4016144642 | 2026-05-07 | Warnings, Adverse reactions | 310537 SX6K58TVWC |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | a58ff524-e975-4d51-a896-e869f8ea6624 | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | c284c146-436b-4eea-9dca-d7d21c82778c | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| glyburide-metformin hydrochloride | GLYBURIDE-METFORMIN HYDROCHLORIDE | A-S Medication Solutions | f43c087a-7135-4a79-8463-fe5e9319da91 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | A-S Medication Solutions | d87dade1-55fe-4e77-91b9-b642022a2b8a | 2026-02-08 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| Glyburide | GLYBURIDE | Preferred Pharmaceuticals Inc. | bc8df889-25e0-49a0-bbec-a3dfae8bbb8a | 2026-01-27 | Warnings, Adverse reactions | 310537 SX6K58TVWC |
| glyburide-metformin hydrochloride | GLYBURIDE-METFORMIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | a0ff8ee6-0da8-40f8-b5b0-a7b334e1a15f | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | SX6K58TVWC |
| Glyburide | GLYBURIDE | A-S Medication Solutions | 51cf08e2-8a2f-4bde-996f-f431f1a68abd | 2026-01-20 | Warnings, Adverse reactions | 310537 SX6K58TVWC |
| Glyburide | GLYBURIDE | NuCare Pharmaceuticals,Inc. | ffd31d06-6011-34e2-e053-6394a90a437f | 2026-01-16 | Warnings, Adverse reactions | 310537 SX6K58TVWC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.